葡萄糖、胰岛素和钾在免疫学和肿瘤学中的意义:一种新的免疫模型。

Albert F Hill, William J Polvino, Darcy B Wilson
{"title":"葡萄糖、胰岛素和钾在免疫学和肿瘤学中的意义:一种新的免疫模型。","authors":"Albert F Hill,&nbsp;William J Polvino,&nbsp;Darcy B Wilson","doi":"10.1186/1476-8518-3-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A recent development in critical care medicine makes it urgent that research into the effect of hormones on immunity be pursued aggressively. Studies have demonstrated a large reduction in mortality as a result of infusion with glucose, insulin and potassium. Our work in the oncology setting has led us to propose that the principal reason for such an effect is that GIK stimulates lymphocytes to proliferate and attack pathogens, sparing the patient the stress of infection. That suggestion is based on a new model of immunity that describes the effect of hormones on lymphocytes. We hypothesized that the application of glucose, insulin, thyroid and potassium would awaken inert tumor infiltrating lymphocytes to destroy the tumor.</p><p><strong>Methods: </strong>The antitumor effect of a thyroxine, glucose, insulin, and potassium (TGIK) combination was studied in a series of controlled experiments in murine models of tumor progression to assess the biologic activity of the formulation, the effect of route of administration, the effect on tumor type, and the requirement for insulin in the TGIK formulation.</p><p><strong>Results: </strong>Melanoma and colon tumors inoculated with TGIK were significantly reduced in size or retarded in growth compared to controls injected with saline. I.P. and I.M. injections showed that the formulation had no effect systemically at the doses administered.</p><p><strong>Conclusion: </strong>We conclude that TGIK has anti-tumor activity when administered intratumorally, probably by stimulating lymphocytes to attack tumors. This is similar to the effect of GIK on reducing sepsis in critical care patients. We suggest that when GIK is administered exogenously, it restores immune competence to the critically ill or cancer patient and causes destruction of pathogens or tumors, while endogenous resources are devoted to repair. This implies that hormonal therapy may be useful in treating various other pathologies involving immune suppression, as well as malignancies. We also propose research that could bring resolution of the controversy over mechanism and point the way to new therapeutic strategies for numerous diseases including chronic infections and auto-immune diseases.</p>","PeriodicalId":84998,"journal":{"name":"Journal of immune based therapies and vaccines","volume":"3 ","pages":"5"},"PeriodicalIF":0.0000,"publicationDate":"2005-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1476-8518-3-5","citationCount":"6","resultStr":"{\"title\":\"The significance of glucose, insulin and potassium for immunology and oncology: a new model of immunity.\",\"authors\":\"Albert F Hill,&nbsp;William J Polvino,&nbsp;Darcy B Wilson\",\"doi\":\"10.1186/1476-8518-3-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>A recent development in critical care medicine makes it urgent that research into the effect of hormones on immunity be pursued aggressively. Studies have demonstrated a large reduction in mortality as a result of infusion with glucose, insulin and potassium. Our work in the oncology setting has led us to propose that the principal reason for such an effect is that GIK stimulates lymphocytes to proliferate and attack pathogens, sparing the patient the stress of infection. That suggestion is based on a new model of immunity that describes the effect of hormones on lymphocytes. We hypothesized that the application of glucose, insulin, thyroid and potassium would awaken inert tumor infiltrating lymphocytes to destroy the tumor.</p><p><strong>Methods: </strong>The antitumor effect of a thyroxine, glucose, insulin, and potassium (TGIK) combination was studied in a series of controlled experiments in murine models of tumor progression to assess the biologic activity of the formulation, the effect of route of administration, the effect on tumor type, and the requirement for insulin in the TGIK formulation.</p><p><strong>Results: </strong>Melanoma and colon tumors inoculated with TGIK were significantly reduced in size or retarded in growth compared to controls injected with saline. I.P. and I.M. injections showed that the formulation had no effect systemically at the doses administered.</p><p><strong>Conclusion: </strong>We conclude that TGIK has anti-tumor activity when administered intratumorally, probably by stimulating lymphocytes to attack tumors. This is similar to the effect of GIK on reducing sepsis in critical care patients. We suggest that when GIK is administered exogenously, it restores immune competence to the critically ill or cancer patient and causes destruction of pathogens or tumors, while endogenous resources are devoted to repair. This implies that hormonal therapy may be useful in treating various other pathologies involving immune suppression, as well as malignancies. We also propose research that could bring resolution of the controversy over mechanism and point the way to new therapeutic strategies for numerous diseases including chronic infections and auto-immune diseases.</p>\",\"PeriodicalId\":84998,\"journal\":{\"name\":\"Journal of immune based therapies and vaccines\",\"volume\":\"3 \",\"pages\":\"5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/1476-8518-3-5\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of immune based therapies and vaccines\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/1476-8518-3-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immune based therapies and vaccines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1476-8518-3-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

摘要

背景:危重医学的最新发展使得激素对免疫作用的研究迫在眉睫。研究表明,由于输注葡萄糖、胰岛素和钾,死亡率大大降低。我们在肿瘤学环境中的工作使我们提出这种效果的主要原因是GIK刺激淋巴细胞增殖并攻击病原体,从而使患者免受感染的压力。这个建议是基于一种新的免疫模型,该模型描述了激素对淋巴细胞的影响。我们假设葡萄糖、胰岛素、甲状腺和钾的应用会唤醒惰性的肿瘤浸润淋巴细胞来破坏肿瘤。方法:采用小鼠肿瘤进展模型,通过一系列对照实验研究甲状腺素、葡萄糖、胰岛素和钾(TGIK)联合制剂的抗肿瘤作用,评估制剂的生物活性、给药途径的影响、对肿瘤类型的影响以及TGIK制剂对胰岛素的需要量。结果:与注射生理盐水的对照组相比,接种TGIK的黑色素瘤和结肠肿瘤的大小明显减小或生长迟缓。单剂量和单剂量注射表明,该制剂在给药剂量下对全身没有影响。结论:肿瘤内给药TGIK可能通过刺激淋巴细胞攻击肿瘤而具有抗肿瘤活性。这与GIK在减少重症患者败血症方面的作用相似。我们认为,当外源性GIK给药时,它可以恢复危重病人或癌症患者的免疫能力,并导致病原体或肿瘤的破坏,而内源性资源用于修复。这意味着激素疗法可能对治疗涉及免疫抑制的各种其他病理以及恶性肿瘤有用。我们还提出了可以解决机制争议的研究,并为包括慢性感染和自身免疫性疾病在内的许多疾病提供新的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The significance of glucose, insulin and potassium for immunology and oncology: a new model of immunity.

The significance of glucose, insulin and potassium for immunology and oncology: a new model of immunity.

The significance of glucose, insulin and potassium for immunology and oncology: a new model of immunity.

The significance of glucose, insulin and potassium for immunology and oncology: a new model of immunity.

Background: A recent development in critical care medicine makes it urgent that research into the effect of hormones on immunity be pursued aggressively. Studies have demonstrated a large reduction in mortality as a result of infusion with glucose, insulin and potassium. Our work in the oncology setting has led us to propose that the principal reason for such an effect is that GIK stimulates lymphocytes to proliferate and attack pathogens, sparing the patient the stress of infection. That suggestion is based on a new model of immunity that describes the effect of hormones on lymphocytes. We hypothesized that the application of glucose, insulin, thyroid and potassium would awaken inert tumor infiltrating lymphocytes to destroy the tumor.

Methods: The antitumor effect of a thyroxine, glucose, insulin, and potassium (TGIK) combination was studied in a series of controlled experiments in murine models of tumor progression to assess the biologic activity of the formulation, the effect of route of administration, the effect on tumor type, and the requirement for insulin in the TGIK formulation.

Results: Melanoma and colon tumors inoculated with TGIK were significantly reduced in size or retarded in growth compared to controls injected with saline. I.P. and I.M. injections showed that the formulation had no effect systemically at the doses administered.

Conclusion: We conclude that TGIK has anti-tumor activity when administered intratumorally, probably by stimulating lymphocytes to attack tumors. This is similar to the effect of GIK on reducing sepsis in critical care patients. We suggest that when GIK is administered exogenously, it restores immune competence to the critically ill or cancer patient and causes destruction of pathogens or tumors, while endogenous resources are devoted to repair. This implies that hormonal therapy may be useful in treating various other pathologies involving immune suppression, as well as malignancies. We also propose research that could bring resolution of the controversy over mechanism and point the way to new therapeutic strategies for numerous diseases including chronic infections and auto-immune diseases.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信